Hemostatic Agents Market Expected To Grow At 5.2% CAGR Through 2030: What Businesses Need To Know
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Hemostatic Agents Market Forecast: Value Set To Climb From $4.66 Billion To $5.71 Billion
The hemostatic agents market size has seen robust expansion in recent years. This market is expected to grow from $4.42 billion in 2025 to $4.66 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. The historical period’s growth can be attributed to a limited variety of hemostatic agents, a reliance on traditional thrombin and gelatin products, an increasing number of surgical procedures, expanding hospital infrastructure, and a growing awareness of blood loss management.
The hemostatic agents market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $5.71 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This anticipated growth during the forecast period is primarily driven by factors such as the advancement of recombinant and sprayable fibrin sealants, the increasing scope of minimally invasive and orthopedic surgical procedures, a surge in the need for multi-agent and combination hemostats, greater uptake in plastic and neurosurgery, and regulatory focus on ensuring sterility and biocompatibility. Key trends defining this period encompass a growing requirement for sophisticated hemostatic agents in surgical settings, wider acceptance of combination and multi-agent hemostats, an increase in the utilization of fibrin sealants and biologically derived solutions, broadened application of hemostats in trauma and cardiovascular operations, and a heightened commitment to safety, sterility, and adherence to regulations.
Get A Free Sample Report With In-Depth Market Insights:
Hemostatic Agents Market Demand Drivers: What’s Powering Industry Growth?
The expanding volume of surgical procedures is projected to spur the growth of the hemostatic agents market moving forward. Surgical procedures encompass medical interventions performed by health professionals utilizing specific instruments to address, repair, or excise parts of the body for health-related objectives. This increase in surgical procedures is largely attributed to the growing prevalence of chronic conditions, which often necessitate surgical intervention to manage health issues and improve patient outcomes. Hemostatic agents are vital in surgeries, as they facilitate rapid bleeding control, thereby reducing blood loss and improving visibility within the surgical area for more precise work. For instance, in October 2025, according to the UK Health Security Agency (UKHSA), a UK-based national government public health agency, surveillance data from the 2023–24 period revealed that 135,619 operations were submitted, with 1,276 surgical site infections (SSIs) detected during inpatient stay or upon readmission, marking an 8.4% increase in submissions compared to the previous year. Therefore, the rising number of surgical procedures is driving the expansion of the hemostatic agents market.
Hemostatic Agents Market Segment Analysis Spotlighting Growth Areas
The hemostatic agents market covered in this report is segmented –
1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types
2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications
3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users
Subsegments:
1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products
2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin
3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches
4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents
5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations
6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials
7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats
Hemostatic Agents Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to provide quick and effective hemostasis and tissue closure for both open and minimally invasive surgeries. Collagen-based hemostats are materials derived from purified collagen that help stop bleeding by enhancing the body’s natural clotting process at a wound or surgical incision site. For instance, in March 2025, Baxter, a US-based healthcare company, unveiled HEMOPATCH Sealing Hemostat, an absorbable pad based on collagen. This innovative collagen-based pad incorporates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, facilitating rapid sealing of bleeding areas. It offers strong adherence to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, meeting critical clinical and storage needs.
Hemostatic Agents Market Key Players Shaping Industry Direction
Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.
View The Full Hemostatic Agents Market Report:
Hemostatic Agents Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
